Cannabis Bioscience International Holdings, Inc. (CBIH): Operating Income
-$421.4K
Year ended 2025-05-31
-$398.8K
Trailing 12 months to 2026-02-28
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-05-31 | -$421.4K | n/m | 2025-09-22, From 2024-06-01 |
| 2024-05-31 | -$486.1K | n/m | 2025-09-22, From 2023-06-01 |
| 2023-05-31 | -$983.4K | n/a | 2024-09-16, From 2022-06-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Cannabis Bioscience International Holdings, Inc. (CBIH) | 2025-05-31 | -$421.4K | n/m |
| OneMedNet Corp (ONMD) | 2025-12-31 | -$9.67M | n/m |
| iSpecimen Inc. (ISPC) | 2025-12-31 | -$8.98M | n/m |
| Absci Corp (ABSI) | 2025-12-31 | -$120.32M | n/m |
| bioAffinity Technologies, Inc. (BIAF) | 2025-12-31 | -$10.57M | n/m |
| Foxo Technologies Inc. (FOXO) | 2025-12-31 | -$10.33M | n/m |
| OmniAb, Inc. (OABI) | 2025-12-31 | -$68.97M | n/m |
| MaxCyte, Inc. (MXCT) | 2025-12-31 | -$51.90M | n/m |
| NRC Health (NRC) | 2025-12-31 | $22.59M | -35.8% |
Compare CBIH, ONMD, ISPC, ABSI side by side · Screen every company in Services-Commercial Physical & Biological Research ↗